🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

550 mcg (458% DV)
📊 4.6× RDA — above typical dose 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.55mg

Other Ingredients

Microcrystalline Cellulose Modified Cellulose Magnesium Stearate Silicon Dioxide

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Directions: As a dietary supplement for adults, take 1 capsule daily with a meal, or as directed by a healthcare professional.

⚠️ Warnings & Precautions

Warning: Do not take this product if you are pregnant or nursing. If you are taking anti-coagulant or anti-platelet medications, have a bleeding disorder, or are planning a medical procedure, consult with a healthcare professional before taking this product.

Do not exceed recommended dose. Do not use if seal under cap is broken or missing.

Keep out of reach of children.

🧪 Formulation Notes

Structurally similar, vitamin K is a set of fat-soluble vitamins that includes two vitamers: vitamin K1 and vitamin K2. While both vitamers are beneficial to the body, vitamin K2 remains biologically active in the body longer than vitamin K1. Futurebiotics vitamin K triple play is designed to provide the benefits of both vitamin K1 and vitamin K2, plus it supplies two different forms of vitamin K2: Menatetrenone-4 (MK-4) and Menquinone-7 (MK-7).

100% Satisfaction Guaranteed

Advanced Formula Full Spectrum Complex

Vitamin K Triple Play with Vitamin K1 and Two Forms of K2

Additional Information

Futurebiotics Health. Nature. Life.

Protect from light.

Product Details

UPC / SKU 0 49479 00636 6
DSLD Entry Date 2024-12-21
Product Type Vitamin
Form Capsule
DSLD ID 319882
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →